Dinosaur DNA? New Patent Covers Degraded DNA recovery
The US Patent Office issued Patent # 6,872,552, "A Method of Reconstituting Nucleic Acid Molecules" today to Burt D. Ensley, Ph.D, Chairman of MatrixDesign, and CEO of DermaPlus, Inc. The patent covers methods for recovering and reconstituting genes from "degraded" DNA samples, and could allow scientists to reassemble everything from prehistoric, extinct animals to unsolved crime scenes. "...Nanogen Issued Patent for Electronic Microarray With Memory
Nanogen, Inc. (Nasdaq: NGEN), developer of advanced diagnostic products, announced today that it was issued U.S. Patent No. 6,867,048, "Multiplexed Active Biologic Array" by the U.S. Patent and Trademark Office. The '048 patent relates to a method of addressing one or more electrodes (or "test sites") across multiple rows and columns of a microarray. The patent also covers a method for storing th...Stratagene to pay Third Wave $10.75M in patent case
The case, which was litigated in U.S. District Court for the We...eBay decision changes balance of power in patent disputes
. The first two parts, written by attorney Gina Carter, pertained to preventing intellectual property infringement within organizations. The following commentary, written by attorneys Joe Goode and Jonathan Fritz, addr...Drug innovation beats marketing, patents and mergers
While Genentech had revenues of $4.6 b...Changes to U.S. patent law must nurture our culture of innovation
Even during an era when America-bashing is back in vogue, there are certain things this country does well - and has always done well - much to the consternation of our rivals and com...WARF questions relevancy of documents used to uphold patent challenge
refu...Indian Doctor granted US patent on organ regeneration
Dr. Balakrishna Ganapat Rao Matapurkar, from Maulana Azad Medical College, New Delhi has created history of sorts by winning the first patent on organ regeneration from the American patent office for his technique in successfully regenerating / repairing organs in human beings. A few weeks ago the American patent office granted him a patent on this technique. Dr. Matapurkar was able to...Dr Reddy’s Laboratories to challenge patents on drug
Pharma major Dr Reddy’s Laboratories will continue to aggressively challenge patents on drugs in the US despite the recent denial of a 180-day marketing exclusivity to its generic Omeprazole 40 mg capsules by the US Food and Drug Administration. Omeprazole is indicated for the treatment of duodenal and gastric ulcers. The FDA granted the marketing exclusivity to Andrx group of the US....Yoga, ayurveda being documented to stop patent misuse
Bitten by patent rows over basmati and turmeric, India doesn't want to be caught off guard again// by the West, certainly not when it comes to its ancient healing systems of yoga, ayurveda, unani and siddha. A task force appointed by the government for protecting traditional knowledge and intellectual property is fast completing the documentation of yoga postures and techniques as wel...Indian Government Keen On JE Vaccine Supply And Patenting Of Indian Medicine Formulations
Health Minister Dr Anbumani Ramadoss, in an attempt to tackle the issue of vaccination against Japanese Encephalitis has left for Beijing to approach China, the only country where the vaccine is available in a sizeable // quantity. The heavy toll of valuable human lives in Uttar Pradesh and Bihar has prompted the initiative by the health Minister. The health minister has also planned f...HIV Patients Opposes Patenting Of AIDS Drug
An Indian group of people living with HIV/AIDS have opposed a patent application filed by global pharma major GlaxoSmithKline for Combivir, a fixed dose combination AIDS drug on the grounds that it would make the treatment unaffordable. // Represented by the Lawyers' Collective HIV/AIDS Unit, the Indian Network of People Living with HIV/AIDS and the Manipur Network of Positive People...CARDIA Patent Foramen Ovale Closure Device
Description:The CARDIA PFO Occluder has been developed for the transvenous closure of Patent Foramen Ovale. Introduced through trans-septal venous sheaths (10-12F) the device offers a safe and reliable method for the percutaneous closure of PFO's including those with aneurysmal septums....CARDIA Patent Ductus Arteriosus Closure Device
Description:The CARDIA PDA Closure Device has been developed for the transvenous closure of the Patent Ductus Arteriosus. Introduced through standard venous sheaths (10-14F) the device offers a safe and reliable method for the percutaneous closure of persistent ductal shunts ranging in size from 2mm-10mm within the ductus.An integral locking delivery and retrieval mechanism prevents premature delivery...